Philips puts forth a buyout offer for Carestream’s HCIS business
Category: #health  By Pankaj Singh  Date: 2019-03-09
  • share
  • Twitter
  • Facebook
  • LinkedIn

Philips puts forth a buyout offer for Carestream’s HCIS business

Royal Philips, the Netherlands-based healthcare technology company, has reportedly entered into an agreement with Carestream Health, a healthcare IT solutions provider, in a bid to acquire its HCIS (Healthcare Information Systems) business.

Reportedly, following the latest acquisition, the expanded healthcare IT business of Philips will feature the enterprise imaging platform of Carestream, including best-in-class VNA, multimedia reporting, operational, clinical & business analytical tools, diagnostic & enterprise viewers and workflow orchestrator, as a part of its wide portfolio. Apparently, Philips, similar to Carestream, has developed a strong global business that is customer-focused and is based on continuous innovation and world-class technical excellence.

Carestream’s HCIS business unit, for the record, offers imaging IT solutions to imaging centers, multi-site hospitals, radiology service providers and specialty medical clinics across the globe. Moreover, the business has formed strong relationships with customers in the high-growth healthcare segments, which further positions it for consistent growth and success.

Robert Cascella, Chief Business Leader of Precision Diagnosis, Royal Philips, was quoted stating that the company collaborates with global healthcare providers in order to connect people, information & technology with a strong commitment to deliver improved health outcomes, better staff experiences, improved patient experience and lower healthcare costs. He added that the latest acquisition is expected to enhance the company’s potential to provide flexible solutions for hospitals and health systems.

Authentic sources revealed that Philip’s excellent combination of successful innovations in workflow optimization, AI-enabled informatics and imaging system platforms with the cloud-based platform for enterprise imaging informatics and complementary geographic footprint of Carestream, is likely to present a concrete foundation for delivering on the promise of precision diagnosis.

The deal is reportedly slated to be concluded by the second half of 2019, subject to regulatory approvals and customary closing conditions. Additional details of the transaction have not yet been disclosed.



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
By Pankaj Singh

While top-notch companies are racing to develop a vaccine for COVID-19, it looks like the United States has secured almost all of the world’s supply of interim drug remdesivir to treat patients with COVID-19.

...

Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
By Pankaj Singh

Bharat Biotech International, a leading Indian biotechnology company, has reportedly announced that its potential coronavirus vaccine, Covaxin, has received Drug Controller General of India (DCGI) approval to start hum...

Seattle Genetics reveals positive data from tisotumab vedotin trial
Seattle Genetics reveals positive data from tisotumab vedotin trial
By Pankaj Singh

Seattle Genetics, Inc., a renowned biotechnology firm that focuses on developing antibody-based cancer treatments, has recently revealed positive topline data from its Phase 2 clinical trial (innovaTV 204) assessing ti...